E-z-paste also known as Barium Sulfate is a human prescription drug labeled by 'E-z-em Canada Inc'. National Drug Code (NDC) number for E-z-paste is 32909-770. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in E-z-paste drug includes Barium Sulfate - .6 g/g . The currest status of E-z-paste drug is Active.

E-z-paste barium sulfate barium sulfate barium sulfate carboxymethylcellulose sodium dimethicone 350 dimethicone 1000 ethyl vanillin glycerin methylparaben propylparaben saccharin sodium silicon dioxide sorbitol trisodium citrate dihydrate water anhydrous citric acid

Drug interactions the presence of barium sulfate formulations in the gi tract may alter the absorption of therapeutic agents taken concomitantly. in order to minimize any potential change in absorption, the separate administration of barium sulfate from that of other agents should be considered.

Indications and usage for use in single contrast radiography of the esophagus, pharynx, hypopharynx and for cardiac series.

Warnings rarely, severe allergic reactions of an anaphylactoid nature, have been reported following administration of barium sulfate contrast agents. appropriately trained personnel and facilities should be available for emergency treatment of severe reactions and should remain available for at least 30 to 60 minutes following administration, since delayed reactions can occur.

General diagnostic procedures which involve the use of radiopaque contrast agents should be carried out under the direction of personnel with the requisite training and with a thorough knowledge of the particular procedure to be performed. a history of bronchial asthma, atopy, as evidenced by hay fever and eczema, or a previous reaction to a contrast agent, warrant special attention. caution should be exercised with the use of radiopaque media in severely debilitated patients and in those with marked hypertension or advanced cardiac disease. caution should be used during the administration of this product to patients with a history of food aspiration or to patients in whom integrity of the swallowing mechanism is unknown. if this product is aspirated into the larynx, further administration should be discontinued immediately. after any barium study of the gi tract, it is important to rehydrate the patient as quickly as possible to prevent impaction of the bowel by barium sulfate. to pre Read more...

Dosage and administration usual dose is one to four teaspoons as required.

Contraindications this product should not be used in patients with known gastric or intestinal perforation or hypersensitivity to barium sulfate products.

Adverse reactions adverse reactions, such as nausea, vomiting, diarrhea and abdominal cramping, accompanying the use of barium sulfate formulations are infrequent and usually mild. severe reactions (approximately 1 in 1,000,000) and fatalities (approximately 1 in 10,000,000) have occurred. procedural complications are rare, but may include aspiration pneumonitis, barium sulfate impaction, granuloma formation, intravasation, embolization and peritonitis following intestinal perforation, vasovagal and syncopal episodes, and fatalities. it is of the utmost importance to be completely prepared to treat any such occurrence.

Drug interactions the presence of barium sulfate formulations in the gi tract may alter the absorption of therapeutic agents taken concomitantly. in order to minimize any potential change in absorption, the separate administration of barium sulfate from that of other agents should be considered.

Usage in pregnancy radiation is known to cause harm to the unborn fetus exposed in utero. therefore, radiographic procedures should only be used when, in the judgement of the physician, its use is deemed essential to the welfare of the pregnant patient.

Overdosage on rare occasions following repeated administration, severe stomach cramps, nausea, vomiting, diarrhea or constipation may occur. these are transitory in nature and are not considered serious. symptoms may be treated according to currently accepted standards of medical care.

Description e-z-paste ® barium sulfate esophageal cream (60% w/w) is a barium sulfate cream for oral administration. each 100 g contains 60 g barium sulfate. barium sulfate, due to its high molecular density is opaque to x-rays and, therefore, acts as a positive contrast and agent for radiographic studies. the active ingredient is barium sulfate and its structural formula is baso 4 . barium sulfate occurs as a fine, white, odorless, tasteless, bulky powder which is free from grittiness. its aqueous suspensions are neutral to litmus. it is practically insoluble in water, solutions of acids and alkalies, and organic solvents. inactive ingredients: carboxymethylcellulose sodium, citric acid, ethyl vanillin, glycerin, methylparaben, propylparaben, purified water, saccharin sodium, simethicone emulsion, sodium citrate, and sorbitol solution.

Clinical pharmacology barium sulfate, due to its high molecular density is opaque to x-rays and, therefore, acts as a positive contrast agent for radiographic studies. barium sulfate is biologically inert and therefore, is not absorbed or metabolized by the body, and is eliminated unchanged from the body.

How supplied e-z-paste ® is supplied in the following quantity: 454 g tube, cat. no. 770; ndc 32909-770-01 manufactured by e-z-em canada inc. for e-z-em, inc. a subsidiary of bracco diagnostics inc. monroe township, nj 08831 tel: 1-516-333-8230 1-800 544-4624 rev. 10/17 cl80e01 tx1887

Information for patients before administration of this product patients should be instructed to: inform their physician if they are pregnant. inform their physician if they are allergic to any drugs or food, or if they have had any prior reactions to barium sulfate products or other contrast agents used in x-ray procedures (see precautions-general ). inform their physician about any other medications they are currently taking.

E-z-paste - barium sulfate esophageal cream ndc: 32909-770-01 e-z-paste label tube

E-z-paste - carton e-z-paste carton label